Last reviewed · How we verify

NCT03703999

Freestyle Libre Use in Real Life: Efficacy and Acceptance

Completed Last updated 27 March 2020
What this trial tests

trial testing Type 1 diabetic patients freestyle libre in Diabetes Mellitus, Type 1 in 100 participants. Completed in 1 September 2019.

Timeline
1 June 2018
Primary endpoint
1 April 2019
1 September 2019

Quick facts

Lead sponsorUniversity of Padova
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date1 June 2018
Primary completion1 April 2019
Estimated completion1 September 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Padova

Who can join

18 and older, any sex, with Diabetes Mellitus, Type 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the study is to evaluate efficacy of freestyle Libre system (flash glucose monitoring) in real life in term of Glycated Haemoglobin reduction and acceptance of the system evaluated through validated questionnaires after 3 and 6 months of device's use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

Other University of Padova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03703999.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing